Maine 2025-2026 Regular Session

Maine House Bill LD710

Introduced
2/20/25  
Refer
2/20/25  
Engrossed
5/22/25  
Enrolled
5/22/25  

Caption

An Act to Expand Access and Reduce Barriers to Access to Naloxone Hydrochloride and Other Opioid Overdose-reversing Medications

Companion Bills

No companion bills found.

Previously Filed As

ME HB222

County Boards of Education - Opioid Overdose-Reversing Medications - Policy Requirements (Naloxone Access Act)

ME LB195

Provide immunity for administration of naloxone, nalmefene, or other federally approved opioid overdose reversal medications

ME S3324

Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.

ME A1693

Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.

ME A3800

Requires institutions of higher education to maintain supply of naloxone hydrochloride nasal spray for opioid overdose emergencies and permits emergency administration of naloxone hydrochloride nasal spray by licensed campus medical professionals and resident assistants.

ME HB852

Educational Institutions - Opioid Overdose-Reversing Medications - Policy Requirements (Protecting Our Kids From Overdoses Act)

ME HB05515

An Act Concerning The Department Of Mental Health And Addiction Services' Recommendations Regarding Access To Opioid Overdose Reversal Medication And Various Revisions To Mental Health And Addiction Statutes.

ME AB1586

Opioid overdose reversal medication: school resource officers.

ME LD1452

An Act to Allow the Emergency Medical Services' Board to Assess Civil Penalties for the Noncompliance of Emergency Medical Services Persons with the Requirement to Administer Naloxone Hydrochloride in Compliance with Trainings and Procedures Developed by the Board

ME SB3588

School Access to Naloxone Act of 2026

Similar Bills

CA AB2562

Alcohol or other drug recovery and treatment programs and facilities: suicide prevention.

CA AB423

Alcoholism or drug abuse recovery or treatment programs and facilities: disclosures.

AZ HB2697

expired opioid antagonists; use

CA AB1037

Public health: substance use disorder.

CA AB1586

Opioid overdose reversal medication: school resource officers.

HI HB1767

Relating To Opioid Antagonists.

HI SB2855

Relating To Opioid Antagonists.

CA SB43

Substance use disorder: addiction treatment referral agencies.